#United States #Los Angeles #Cenegenics #MDLifespan #PlasmaXchange

MDLifespan and Cenegenics Join Forces to Enhance Therapeutic Plasma Exchange Across the Nation

MDLifespan, a physician-led medical technology firm recognized as a certified Public Benefit Corporation, has recently announced a significant partnership with Cenegenics, a prominent figure in age management and performance health medicine. This collaboration aims to expand access to Therapeutic Plasma Exchange (TPE) across the United States, addressing chronic inflammation linked to environmental toxins—a pressing health issue in today’s world.

The Essence of Their Partnership

Cenegenics has been a pioneer in improving patient health through thorough diagnostics and individualized, doctor-led programs for decades. By integrating MDLifespan's patented PlasmaXchange protocols, Cenegenics is stepping up its game by focusing on eliminating barriers to health improvement instead of merely adding more treatments. This collaboration will kick off in major cities, including Los Angeles (specifically Beverly Hills), Miami, and Atlanta.

A New Approach to Managing Disease

The rise in chronic inflammation has become a critical public health concern, driving various health problems from cognitive decline to metabolic dysfunction and cardiovascular issues. Despite growing investments in personalized nutrition, fitness, and preventive healthcare, many still struggle to achieve lasting results—often due to the unrecognized burden of environmental toxins present in the bloodstream.

MDLifespan was established to tackle this challenge head-on. Utilizing Advanced TPE protocols, their approach specifically targets harmful elements such as microplastics, PFAS, heavy metals, and pesticides, aiming to facilitate overall health and wellness.

The Innovative Twist of MDLifespan’s TPE

Although Therapeutic Plasma Exchange, or plasmapheresis, isn't a novel concept, MDLifespan’s implementation offers a unique protocol-driven approach, emphasizing the removal of environmental toxins coupled with nutritional support and educational efforts around toxin avoidance. This innovative model transforms plasma exchanges from episodic medical interventions into proactive, repeatable strategies designed to mitigate modern toxin exposure, delivering results that often exceed regular TPE by over 300%.

MDLifespan’s methods are backed by a formal partnership with the University of South Florida’s Morsani College of Medicine and guided by an esteemed advisory board full of high-profile clinicians from various specialties, including cardiology, neurology, immunology, and functional medicine.

Addressing the Global Problem of Toxin Exposure

Cenegenics has earned a reputation over the years for helping individuals optimize their health through personalized and advanced medical approaches. With MDLifespan’s PlasmaXchange methodologies now part of their health program, Cenegenics can better focus on removing obstacles to wellness instead of merely introducing additional layers of treatment. Kristy Berry, CEO of Cenegenics, stated, "The future of longevity medicine necessitates both optimizing biological functions and actively eliminating factors that impair them. The rise of environmental toxins has become a root cause of inflammation, metabolic imbalance, and accelerated aging. Our partnership enables us to offer a reliable, physician-driven solution that directly targets these issues while raising human performance standards to unprecedented levels."

Elevating TPE into Performance Health

This collaboration signifies a crucial shift in the medical field, moving a therapy previously limited to hospital settings into a wellness-focused, physician-led performance health environment. As the incidence of environmental toxin exposure continues to increase, MDLifespan and Cenegenics are strategically positioning regular TPE sessions as a fundamental measure for addressing inflammation, alongside comprehensive diagnostics and preventive healthcare strategies.

Dr. Paul Savage, Founder, and Chief Medical Officer of MDLifespan remarked, "This partnership represents a vital transformation in the delivery of performance care. Cenegenics specializes in maximizing bodily systems, while MDLifespan confronts the vile environmental and inflammatory factors that disrupt these systems. By merging optimization efforts with specific toxin-removal strategies, we are offering a previously unavailable comprehensive care model on a broad scale."

For more information about MDLifespan or to book a consultation, please visit MDLifespan. To discover Cenegenics’ personalized, physician-centric method to performance health and longevity, visit Cenegenics.

About MDLifespan

MDLifespan is a pioneering medical technology startup characterized by its physician-led approach and certified Public Benefit Corporation status. They focus on advanced detoxification and regenerative solutions through their innovations in Therapeutic Plasma Exchange, primarily aimed at removing environmental toxins and counteracting chronic inflammation through validated techniques.

About Cenegenics

Founded in 1997, Cenegenics stands as the globally acknowledged leader in performance health and longevity medicine. Their programs are rooted in personalized, physician-led initiatives, characterized by comprehensive biomarker assessments, cutting-edge diagnostics, research-backed therapies, and a continual optimization focus.

Contact: Jessica Rafaeil
Phone: 4049360191
Email: [email protected]